scPharmaceuticals Stock Price - SCPH

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
scPharmaceuticals Inc SCPH NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.58 -11.07% 4.66 5.22 4.66 5.22 5.24 11:50:18
Bid Price Ask Price Spread Spread % News
4.65 4.85 0.20 4.12% - 1
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
58 27,208 $ 4.90 $ 133,230 36,416 2.44 - 7.8525
Last Trade Time Type Quantity Stock Price Currency
11:49:44 10 $ 4.755 USD

scPharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 86.59M 18.58M $ -29.44M -1.59 - 18.50M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

scPharmaceuticals News

Loading Messages....

Latest SCPH Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SCPH Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week5.155.654.515.1617,447-0.49-9.51%
1 Month6.256.4554.515.4531,378-1.59-25.44%
3 Months6.507.85254.516.0945,714-1.84-28.31%
6 Months3.517.85252.785.0155,6311.1532.76%
1 Year5.207.85252.444.3750,170-0.54-10.38%
3 Years14.2518.172.447.8064,541-9.59-67.3%
5 Years14.2518.172.447.8064,541-9.59-67.3%

scPharmaceuticals Description

scPharmaceuticals Inc is a pharmaceutical company. Its pipeline includes products in various stages of clinical and non-clinical development. It focuses on proven pharmaceutical products in the cardiovascular and infectious disease therapeutic areas. The company's lead product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.